Renaud Bertrand Maloberti - Net Worth and Insider Trading

Renaud Bertrand Maloberti Net Worth

The estimated net worth of Renaud Bertrand Maloberti is at least $23 dollars as of 2024-05-15. Renaud Bertrand Maloberti is the Chief Commercial Officer of ENDRA Life Sciences Inc and owns about 79 shares of ENDRA Life Sciences Inc (NDRA) stock worth over $23. Details can be seen in Renaud Bertrand Maloberti's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Renaud Bertrand Maloberti has not made any transactions after 2021-01-13 and currently still holds the listed stock(s).

Transaction Summary of Renaud Bertrand Maloberti

Renaud Bertrand Maloberti Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Renaud Bertrand Maloberti owns 3 companies in total, including ENDRA Life Sciences Inc (NDRAU) , Bionik Laboratories Corp (BNKL) , and ENDRA Life Sciences Inc (NDRA) .

Click here to see the complete history of Renaud Bertrand Maloberti’s form 4 insider trades.

Insider Ownership Summary of Renaud Bertrand Maloberti

Ticker	Comapny	Transaction Date	Type of Owner
NDRAU	ENDRA Life Sciences Inc	2020-10-01	Chief Commercial Officer
BNKL	Bionik Laboratories Corp	2018-06-11	Chief Commercial Officer
NDRA	ENDRA Life Sciences Inc	2021-01-13	Chief Commercial Officer

Renaud Bertrand Maloberti Latest Holdings Summary

Renaud Bertrand Maloberti currently owns a total of 1 stock. Renaud Bertrand Maloberti owns 79 shares of ENDRA Life Sciences Inc (NDRA) as of January 13, 2021, with a value of $23.

Latest Holdings of Renaud Bertrand Maloberti

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
NDRA	ENDRA Life Sciences Inc	2021-01-13	79	0.29	23

Holding Weightings of Renaud Bertrand Maloberti

Renaud Bertrand Maloberti Form 4 Trading Tracker

According to the SEC Form 4 filings, Renaud Bertrand Maloberti has made a total of 6 transactions in ENDRA Life Sciences Inc (NDRA) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in ENDRA Life Sciences Inc is the sale of 1,000 shares on January 13, 2021, which brought Renaud Bertrand Maloberti around $21,600.

Insider Trading History of Renaud Bertrand Maloberti

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Renaud Bertrand Maloberti Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Renaud Bertrand Maloberti Ownership Network

Ownership Network List of Renaud Bertrand Maloberti

No Data

Ownership Network Relation of Renaud Bertrand Maloberti

Renaud Bertrand Maloberti Owned Company Details

What does ENDRA Life Sciences Inc do?

Who are the key executives at ENDRA Life Sciences Inc?

Renaud Bertrand Maloberti is the Chief Commercial Officer of ENDRA Life Sciences Inc. Other key executives at ENDRA Life Sciences Inc include Chief Technology Officer Michael Milos Thornton , Chief Financial Officer David R. Wells , and director & Chief Executive Officer Francois Roger Michelon .

ENDRA Life Sciences Inc (NDRAU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ENDRA Life Sciences Inc (NDRAU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ENDRA Life Sciences Inc (NDRAU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ENDRA Life Sciences Inc (NDRAU)'s detailed insider trading history can be found in Insider Trading Tracker table.

ENDRA Life Sciences Inc Insider Transactions

No Available Data

What does Bionik Laboratories Corp do?

Who are the key executives at Bionik Laboratories Corp?

Renaud Bertrand Maloberti is the Chief Commercial Officer of Bionik Laboratories Corp. Other key executives at Bionik Laboratories Corp include director & 10 percent owner Remi Gaston-dreyfus , director & Chairman Andre-jacques Auberton-herve , and Executive Vice President & CFO Daniel Gonsalves .

Bionik Laboratories Corp (BNKL) Insider Trades Summary

Over the past 18 months, Renaud Bertrand Maloberti made no insider transaction in Bionik Laboratories Corp (BNKL). Other recent insider transactions involving Bionik Laboratories Corp (BNKL) include a net purchase of 650,000 shares made by Andre-jacques Auberton-herve , a net purchase of 180,555 shares made by Remi Gaston-dreyfus , and a net purchase of 180,555 shares made by Charles Matine .

In summary, during the past 3 months, insiders sold 0 shares of Bionik Laboratories Corp (BNKL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Bionik Laboratories Corp (BNKL) were sold and 1,011,110 shares were bought by its insiders, resulting in a net purchase of 1,011,110 shares.

Bionik Laboratories Corp (BNKL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Bionik Laboratories Corp Insider Transactions

No Available Data

What does ENDRA Life Sciences Inc do?

Who are the key executives at ENDRA Life Sciences Inc?

Renaud Bertrand Maloberti is the Chief Commercial Officer of ENDRA Life Sciences Inc. Other key executives at ENDRA Life Sciences Inc include Chief Technology Officer Michael Milos Thornton , director & Chief Executive Officer Francois Roger Michelon , and Senior Director & Finance Irina Pestrikova .

ENDRA Life Sciences Inc (NDRA) Insider Trades Summary

Over the past 18 months, Renaud Bertrand Maloberti made no insider transaction in ENDRA Life Sciences Inc (NDRA). Other recent insider transactions involving ENDRA Life Sciences Inc (NDRA) include a net purchase of 16,500 shares made by Michael Milos Thornton , a net purchase of 83,333 shares made by Anthony Digiandomenico , and a net purchase of 10,000 shares made by Alexander Y Tokman .

In summary, during the past 3 months, insiders sold 0 shares of ENDRA Life Sciences Inc (NDRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ENDRA Life Sciences Inc (NDRA) were sold and 100,333 shares were bought by its insiders, resulting in a net purchase of 100,333 shares.

ENDRA Life Sciences Inc (NDRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

ENDRA Life Sciences Inc Insider Transactions

No Available Data

Renaud Bertrand Maloberti Mailing Address

Above is the net worth, insider trading, and ownership report for Renaud Bertrand Maloberti. You might contact Renaud Bertrand Maloberti via mailing address: 10 Acorn Way, Georgetown Ma 01833.

Discussions on Renaud Bertrand Maloberti

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.